The MAKO robotic system is FDA-cleared technology used globally for total and partial knee replacements. In Turkey, this procedure is safe when performed at JCI-accredited facilities using the same Stryker-patented surgical precision standards, 3D CT planning, and haptic boundaries found in top-tier United States orthopedic centers.
- FDA clearance: Stryker MAKO system received FDA clearance for knee procedures in 2006 and 2015.
- Safety standards: Major Turkish hospitals like Memorial Şişli maintain Joint Commission International (JCI) accreditation.
- Surgical precision: Robotic assistance allows bone cuts within 0.25mm, reducing soft tissue trauma and pain.
- High success: Reputable Turkish centers report efficacy rates between 90% and 95% for robotic knee replacements.
Bookimed Expert Insight: While many clinics offer robotic surgery, the 5-day inpatient stays at hospitals like Memorial Bahçelievler provide a safety buffer. Most US outpatient models prioritize quick discharge, but Turkey’s extended clinical monitoring helps manage early physical therapy and reduces immediate post-op travel risks. High-volume surgeons here, such as Dr. Erden Erturer, have completed over 500 MAKOplasty procedures, matching the experience levels of top Western specialists.
Patient Consensus: Patients emphasize focusing on the surgeon’s personal MAKO case volume rather than just the clinical technology. They often highlight that choosing JCI-accredited centers in Istanbul ensures the same equipment and safety protocols as high-end American hospitals.